Research & insights

Market notes, portfolio thinking and investing ideas from the Empirica desk.

WHAT LANDS IN YOUR INBOX

Three newsletters. One is free forever.

WEEKLY - FREE

Signal

Learn how to find investment ideas, position building, entry & exit strategies in the Indian markets. If you are new to the markets this is for you.

BI-MONTHLY - PAID

Selection

Learn what entered our watchlist at Empirica India and what left it. The screen that flagged it, the test it passed or failed, and the entry zone we would want.

MONTHLY - PAID

Positioning

The full institutional deep dive on one company: forward fundamental analysis, scenario valuations, governance review, FII/DII analysis, the technical checklist, entry, stop and sizing.

Empirica Signal: Q2 FY27 Earnings Update, What we purchased this week & Market Health, 12 Nov 2026
Signal 12 Nov 2026 · 4 min read

Empirica Signal: Q2 FY27 Earnings Update, What we purchased this week & Market Health, 12 Nov 2026

Two weeks ago, 13 of our portfolio companies had reported results for July to September 2026 (Q2 of the 2026–27 financial year, or Q2 FY27). Now 22 of 25 have reported, and 11 of them beat our expectations. In the last four trading days the Nifty Smallcap 250 rose about 3% and closed on Thursday above both its 10-day and 50-day averages. By our rules, that is a healthy market to put fresh money to work, and we have started: this week we added to two holdings.

Read more
Empirica Signal: Q2 FY27 earning updates for portfolio companies and market health as on 1st Nov'26
Signal 01 Nov 2026 · 4 min read

Empirica Signal: Q2 FY27 earning updates for portfolio companies and market health as on 1st Nov'26

Results season for the July to September 2026 quarter (Q2 of the 2026–27 financial year, or Q2 FY27) is in full swing. 13 of our 23 portfolio companies have reported. 6 beat our expectations, 4 met them and 3 fell short. The other 10 report in the coming weeks. At the same time, the Nifty Smallcap 250 may be turning lower again after a short pause last week. A fall towards 16,000 is possible, so we are careful with fresh money.

Read more
Empirica
Signal 28 Oct 2026 · 3 min read

Empirica Signal: Why and What we bought in the recent fall

In the last 20 days we put ₹9.23 lakh of fresh money to work: 9 purchases across 8 companies, all of them companies we already own. That breaks the rule we have repeated in our weekly Market Health signal, which said to hold fresh money while the Nifty Smallcap 250 sat below its 10-day and 50-day averages. We broke it on purpose. Our rulebook has one exception, and last week the market met it.

Read more
BlueStone Jewellery: Turnaround is real now
Selection 24 Oct 2026 · 17 min read

BlueStone Jewellery: Turnaround is real now

Revenue grew 43.9% to ₹738 crore, same-store sales grew 28%, and operating profit on the company’s preferred measure nearly tripled to ₹53.5 crore. This note sets out what the quarter actually showed, what we think the market got right, and what it may have missed.

Read more
Why we are buying Spectrum Electrical Industries since 23/09/26?
Selection 05 Oct 2026 · 18 min read

Why we are buying Spectrum Electrical Industries since 23/09/26?

A family-run factory in Jalgaon, Maharashtra, makes the small precision parts that sit inside the circuit breakers sold by some of the world’s largest electrical companies. For thirty years almost nobody outside the industry noticed. In the last twelve months its sales grew 31%, its profit grew 75%, and its latest quarter grew 80%. HDFC Mutual Fund and four other institutions have put ₹325 crore into it. Its lenders have upgraded it twice in nine months.

Read more